Literature DB >> 11390625

Expression of Moloney murine leukemia virus RNase H rescues the growth defect of an Escherichia coli mutant.

A G Campbell1.   

Abstract

A 157-amino-acid fragment of Moloney murine leukemia virus reverse transcriptase encoding RNase H is shown to rescue the growth-defective phenotype of an Escherichia coli mutant. In vitro assays of the recombinant wild-type protein purified from the conditionally defective mutant confirm that it is catalytically active. Mutagenesis of one of the presumptive RNase H-catalytic residues results in production of a protein variant incapable of rescue and which lacks activity in vitro. Analyses of additional active site mutants demonstrate that their encoded variant proteins lack robust activity yet are able to rescue the bacterial mutant. These results suggest that genetic complementation may be useful for in vivo screening of mutant viral RNase H gene fragments and in evaluating their function under conditions that more closely mimic physiological conditions. The rescue system may also be useful in verifying the functional outcomes of mutations based on protein structural predictions and modeling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390625      PMCID: PMC114339          DOI: 10.1128/JVI.75.13.6212-6217.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Functional analysis of the domain organization of Trypanosoma brucei RNase HI.

Authors:  J H Kobil; A G Campbell
Journal:  Biochem Biophys Res Commun       Date:  2000-04-13       Impact factor: 3.575

2.  Molecular diversities of RNases H.

Authors:  N Ohtani; M Haruki; M Morikawa; S Kanaya
Journal:  J Biosci Bioeng       Date:  1999       Impact factor: 2.894

3.  Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.

Authors:  N Tanese; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

4.  Metal binding and activation of the ribonuclease H domain from moloney murine leukemia virus.

Authors:  E R Goedken; S Marqusee
Journal:  Protein Eng       Date:  1999-11

5.  Effects of mutations in the polymerase domain on the polymerase, RNase H and strand transfer activities of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  H Q Gao; P L Boyer; E Arnold; S H Hughes
Journal:  J Mol Biol       Date:  1998-04-03       Impact factor: 5.469

6.  Nuclease activities of Moloney murine leukemia virus reverse transcriptase. Mutants with altered substrate specificities.

Authors:  S W Blain; S P Goff
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

7.  Selective cloning of genes encoding RNase H from Salmonella typhimurium, Saccharomyces cerevisiae and Escherichia coli rnh mutant.

Authors:  M Itaya; D McKelvin; S K Chatterjie; R J Crouch
Journal:  Mol Gen Genet       Date:  1991-07

8.  Differential effects of Moloney murine leukemia virus reverse transcriptase mutations on RNase H activity in Mg2+ and Mn2+.

Authors:  S W Blain; S P Goff
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

9.  Folding the ribonuclease H domain of Moloney murine leukemia virus reverse transcriptase requires metal binding or a short N-terminal extension.

Authors:  E R Goedken; S Marqusee
Journal:  Proteins       Date:  1998-10-01

10.  Substitution of a highly basic helix/loop sequence into the RNase H domain of human immunodeficiency virus reverse transcriptase restores its Mn(2+)-dependent RNase H activity.

Authors:  J L Keck; S Marqusee
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

View more
  1 in total

1.  Ultradeep pyrosequencing and molecular modeling identify key structural features of hepatitis B virus RNase H, a putative target for antiviral intervention.

Authors:  Juliette Hayer; Christophe Rodriguez; Georgios Germanidis; Gilbert Deléage; Fabien Zoulim; Jean-Michel Pawlotsky; Christophe Combet
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.